Alyeska Investment Group
RARX

Alyeska Investment Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Alyeska Investment Group’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-463,613
Closed -$22.3M – 598
2020
Q1 		$22.3M Sell
463,613
-314,339
-40% -$14.6M 0.44% 81
2019
Q4 		$36.5M Buy
+777,952
New +$34.4M 0.48% 76

Other funds holding RARX

Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Alyeska Investment Group's RARX Position: Q2 2020 in Review

Alyeska Investment Group sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 463,613 shares — an estimated $22.3M sold.

Alyeska Investment Group first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $36.5M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

  • Alyeska Investment Group reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 463,613 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $22.3M.
  • Alyeska Investment Group first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Alyeska Investment Group's Ra Pharmaceuticals, Inc. Common Stock position peaked at $36.5M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Alyeska Investment Group's 13F filing for Q2 2020, filed 14 Aug 2020.